CGClara Gómez

Clara Gómez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Clara Gómez has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combination of Q-switched 1,064 and 532 nm Nd: YAG laser in the treatment of toenail onychomycosis: a pilot study

    by Clara Gómez, Enrique Alberdi

    Previous studies have demonstrated that laser-based therapies can effectively improve the appearance of nails affected by onychomycosis, offering a high safety margin, making them suitable for patients in whom systemic antifungal agents are contraindicated. Building on earlier studies, a pilot clinical trial was designed to assess the effectiveness of a Q-switched Nd: YAG laser using dual wavelengths (1,064 nm and 532 nm) for the treatment of toenail onychomycosis. This study involved 15 participants with distal lateral subungual onychomycosis (DLSO) of the big toe caused by dermatophytes. Each laser session included two applications of 1,064 Nd: YAG laser at 600 mJ/pulse, 20 ns, 2 Hz, for 1 min, separated by a 1-minute pause. After a 2-minute rest, the 532 nm laser was applied in a similar manner using the same parameters. Treatments were administered weekly over eight weeks. Progress was monitored using the Onychomycosis Severity Index (OSI), based on direct clinical examination and photographs taken at baseline, during each session, and at follow-up visits. Mycological clearance was assessed via PAS-stained histopathology and fungal culture. Pain during treatment was evaluated using a visual analogue scale (VAS), and any side effects were recorded. At week 43, both mycological cure rate (MCR) and complete cure rate (CCR) were 33.3% (5 out 15 patients). The laser therapy was well-tolerated, with no reported adverse effects. Pain scores averaged 6.5 ± 0.5 during the 1,064 nm application and 7.8 ± 0.5 during the 532 nm application. Despite some discomfort, patient satisfaction remained high. The dual-wavelength Q-switched Nd: YAG laser appears to be a promising treatment option for mild onychomycosis, although its effectiveness is limited in severe onychomycosis. Further research is needed to optimize laser parameters, session frequency, and follow-up duration to maximize therapeutic outcomes.


  • Open Access

    Light-Based Therapies for Treatment of Onychomycosis

    by Clara Gómez, Enrique Alberdi

    Onychomycosis is a chronic fungal infection of the nail, and its treatment is considered a challenge. The use of systemic antifungals is frequently associated with multiple adverse effects; moreover, topical antifungals are rarely effective when used as a monotherapy. Non-pharmacological alternative treatment modalities are needed. Progress in this direction includes experimentation with light-based therapies: administration of laser radiation through the use of long-pulsed and Q-switched Nd:YAG, CO2 , infradiode, fractional ablative lasers, and other light sources for photodynamic therapy or intense pulsed light (IPL). These therapies exert their effect through various mechanisms: selective photothermolysis, a non-selective thermal effect that decomposes the infected tissue and has a sterilizing effect, or the induction of photochemical reactions, damaging fungal structures. Well-designed clinical trials are still needed to assess efficacy and establish the best treatment guidelines. It is expected that technological innovation will enable the design of more advanced light devices, enhancing their efficacy and achieving a positive societal impact.


  • Open Access

    Láseres ablativos fraccionados en onicomicosis

    by C. Gómez, E. Alberdi

  • Open Access

    Medium‐term antifungal effects of methylene blue versus flavin mononucleotide in the treatment of moderate toenail onychomycosis

    by Clara Gómez, Georg Schuele, Enrique Alberdi

    Background: Methylene blue (MB) and flavin mononucleotide (FMN)‐mediated photodynamic therapy (PDT) have demonstrated local antimicrobial effect, but no direct comparative study has been published so far for the treatment of toenail onychomycosis.Objectives: To directly compare the short and medium‐term efficacy of MB versus FMN as photosensitizers in PDT for toenail onychomycosis by applying them in a 40% w/w urea cream in two different dye concentrations.Methods: Forty toenails with distal and lateral subungual moderate onychomycosis due to dermatophyte fungi were randomised to receive 10 weekly sessions of PDT mediated by four topical formulations including MB or FMN at two different concentrations: Group I: 0.1% w/w MB; Group II: 2% w/w MB; Group III: 0.1% w/w FMN; and Group IV: 2% w/w FMN. Photographs were used for onychomycosis severity index (OSI) estimation allowing clinical assessment at any point of the study. Microscopic and microbiological evaluations were carried out at baseline, 27‐ and 35‐week follow‐ups. Side effects were recorded along with patient satisfaction.Results: At week 27, mycological cure rates were 60%, 30%, 50% and 40% and complete cure rates were 0%, 20%, 10% and 20%, for Groups I, II, III and IV respectively. At week 35, mycological cure rates were 70%, 70%, 70% and 60% and complete cure rates were 30%, 50%, 70% and 30%, for Groups I, II, III and IV respectively. All cream formulations were safe and patients were fairly satisfied.Conclusions: Results of the present work confirm PDT as a therapeutic alternative for onychomycosis. Although all cream formulations were safe and effective, with a good degree of satisfaction, higher cure rates were obtained with 2% w/w MB cream and 0.1% w/w FMN cream.


  • Open Access

    Urea versus fractional Er:YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate toenail onychomycosis: short- and medium-term effects

    by Enrique Alberdi, Clara Gómez

    Keratolytic properties of urea 40% have long time used for the treatment of onychomycosis. Fractional ablative lasers enhance the delivery of topically applied photosensitizers improving photodynamic therapy (PDT) efficacy. The aim of this study was to compare the short- and medium-term efficacy of a pretreatment with urea 40% and fractional Er:YAG (Fr Er:YAG) laser radiation before PDT mediated by methylene blue (MB) for moderate toenail onychomycosis. Twenty-first-toe toenails were randomized to receive either urea 40% (Group I) or Fr Er:YAG laser (Group II) pretreatment and 9 sessions of MB/PDT over the course of 16 weeks. At baseline, 28- and 40-week follow-ups, clinical efficacy was assessed by digital photographs [allowing determination of the onychomycosis severity index (OSI)], whereas mycological efficacy was assessed by histological examination and fungal culture. Details of the side effects and patients’ satisfaction were also recorded. In both groups, a significant decrease in OSI values was observed at the 28-week follow-up and a slight rebound at the 40-week follow-up. The percentage of nail involvement decreased significantly in both groups at the 28-week follow-up, to continue declining gently in Group I at 40 weeks, in contrast to the rebound observed during this period in Group II. The mycological cure rate was 20% and 30% at 28-week follow-up and 70% and 40% at 40-week follow-up, in Group I and II, respectively. Patients reported being fairly satisfied, and no side effects were detected in any groups. Although both pretreatments favor the action of PDT for the treatment of onychomycosis, the use of urea at 40% is more effective in the medium term.


  • Effects of Photobiomodulation on the Upper First Molar Intrusion Movement Using Mini-Screws Anchorage: A Randomized Controlled Trial

    by Rosa Abellán, Clara Gómez, Juan Carlos Palma

    Objective: The aim of this study was to quantify the changes obtained when the molar intrusion movement is complemented by photobiomodulation (PBM). Background: A common problem in adult patients is the super-eruption of maxillary molars caused by the loss of the antagonist tooth. Super-erupted molars impair oral rehabilitation and can cause both occlusal and functional problems. There is increasing research confirming the benefits of adjunctive PBM during orthodontic treatment. Methods: Twenty patients with indication of a maxillary first molar intrusion for oral rehabilitation were selected. Patients were randomized into two groups to receive orthodontic intrusion (control group) or the same treatment complemented by PBM (PBM group) in repeated doses (days 0, 1, 2, 3, 4, and 7 from the start of the intrusion and in each monthly follow-up) by using a low-power red laser diode (670 nm, 150 mW, 12 min around the molar). Plaque index (PI), probing depth (PD), and bleeding of probing (BOP) were assessed at 0, 1, 2, 3, and 6 months. Stereolithography models generated from an intraoral scanner were taken at 0, 3, and 6 months and cone beam computed tomography (CBCT) records were taken at 0 and 6 months. Mean intrusion distance, mean intrusion velocity, and volumetric resorption were calculated. Results: Periodontal clinical assessments (PI, PD, and BOP) and mean intrusion distance or mean intrusion velocity yielded no differences ( p > 0.05) between groups. However, PBM group showed lower values of all these scores during the first 3 months. Intraoral scanner and CBCT were equally effective in accurately monitoring the intrusion distance ( p > 0.05). CBCT records allowed volumetric evaluation of the root resorption process, being lesser in the PBM group, but not significantly ( p > 0.05). Conclusions: During orthodontic intrusion process, the adjunctive application of PBM may provide better periodontal records and lower progression of root resorption at the expense of a little lower intrusion distance and velocity.


  • Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild‐to‐moderate toenail onychomycosis: Short‐ and medium‐term effects

    by Enrique Alberdi, Clara Gómez

    Photodynamic therapy (PDT) has emerged as an interesting alternative option for onychomycosis treatment. The impact of a specific photosensitizer (PS) on the final result is an important factor to consider. We conducted a short‐ and medium‐term controlled trial to compare the effectiveness of PDT in the treatment of mild‐to‐moderate onychomycosis when it is mediated by two different PSs. Twenty patients were randomized to receive 9 sessions of PDT distributed over 16 weeks mediated either by methylene blue (MB/PDT group) or methyl aminolevulinate (MAL/PDT group). Onychomycosis severity index (OSI) and nail involvement were checked along the study. Complete cure, treatment success and clinical improvement were tabulated at 16 and 40‐week follow‐ups. OSI scores decreased significantly along the study, from 12.1±5.4 to 3.6±3.2 (MB/PDT group) and from 14.8±6.0 to 5.4±4.4 (MAL/PDT group). At 16‐week follow‐up, only 20% of the patients in the MB/PDT group reached complete cure and none in the group of MAL/PDT. At 40‐week follow‐up, complete cure rates were 70% and 40% in the MB/PDT group and MAL/PDT group respectively. Both modalities showed good outcomes in treatment of moderate toenail onychomycosis. MB/PDT showed a faster action but with relapse rates slightly higher than MAL/PDT.


  • Methylene blue vs methyl aminolevulinate photodynamic therapy in combination with oral terbinafine in the treatment of severe dermatophytic toenail onychomycosis: Short‐ and long‐term effects

    by Enrique Alberdi, Clara Gómez

    Background: Photodynamic therapy (PDT) kills target microorganisms via reactive oxygen species (ROS) production. PDT seems to be a good alternative treatment option for onychomycosis.Objective: To compare the efficacy of combined therapies based on oral terbinafine (TN) plus adjunctive PDT mediated by methylene blue (MB) (TN + MB/PDT) or methyl aminolevulinate (MAL) (TN + MAL/PDT) in the treatment of onychomycosis.Methods: Twenty patients affected by severe dermatophyte onychomycosis in the nails of the big toe (>60% disease involvement of target nail) received oral TN for 12 weeks and concomitantly were randomly allocated to receive nine sessions, separated by 2‐week intervals, of urea (40%) plus a PDT protocol mediated by MB (TN + MB/PDT: group I) or mediated by MAL (TN + MAL/PDT: group II). Clinical and mycological efficacy was evaluated at 16‐, 40‐ and 52‐week follow‐up.Results: Both protocols showed a significant decrease in Onychomycosis Severity Index (OSI) scores (P < .05), from 24.2 ± 4.6 to 0.7 ± 0.6 (group I)) and from 18.5 ± 10.1 to 2.1 ± 2.0 (group II). No side effects or complications were reported in any of the combinations used. Mycological cure rates were significantly higher during the last third of the evaluated period of time, reaching 100% and 90% in group I and group II, respectively, at the 52‐week follow‐up. In both modalities, complete cure was achieved in 70% of the patients at the 52‐week follow‐up.Conclusions: TN + MB/PDT and TN + MAL/PDT show similar outcomes in the treatment of toenails with severe onychomycosis. PDT is an effective method to accelerate the TN‐mediated healing process.